Frontlight ResearchEarly access
Trial site
Ankang Central Hospital
- 6running trials
- 2closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- Stroke3 trials
- Hepatitis B2 trials
- Ulcerative colitis2 trials
- Gastric and oesophageal cancer1 trial
- Liver and biliary tract cancer1 trial
- Phase
- Phase 32 trials
- Phase 42 trials
- Status
- Not yet recruiting3 trials
- Recruiting3 trials
- Completed2 trials
- Lead sponsor
- Xijing Hospital of Digestive Diseases2 trials
- Beijing 302 Hospital1 trial
- Beijing Tiantan Hospital1 trial
- Peking University First Hospital1 trial
- Southwest Hospital, China1 trial
- and 2 more
Running trials
Recruiting
Upadacitinib Versus Infliximab as Second-Line Treatment for Acute Severe Ulcerative Colitis(UPRISE)
Not yet recruiting
Recruiting
Not yet recruiting
Not yet recruiting
A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B
Recruiting
Antithrombotic Drug Use in Patients With Ischemic Stroke and Microbleeds
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Hepatitis B2 recruiting
- Stroke2 recruiting
- Ulcerative colitis2 recruiting
- Liver and biliary tract cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026